Literature DB >> 7940748

Ethylcarbodiimide as an agent for induction of specific transplant tolerance.

C Elliott1, K Wang, S Miller, R Melvold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7940748     DOI： 10.1097/00007890-199410270-00023

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

Review 1.  Molecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  Immunol Rev       Date:  2009-05       Impact factor: 12.988

Review 2.  Cell Membrane Bioconjugation and Membrane-Derived Nanomaterials for Immunotherapy.

Authors:  Peter Y Li; Zhiyuan Fan; Hao Cheng
Journal:  Bioconjug Chem       Date:  2018-01-11       Impact factor: 4.774

Review 3.  Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells.

Authors:  D P McCarthy; J Bryant; J P Galvin; S D Miller; X Luo
Journal:  Am J Transplant       Date:  2015-03-23       Impact factor: 8.086

4.  Ethylenecarbodiimide-coupled allogeneic antigen presenting cells induce human CD4+ regulatory T cells.

Authors:  Michael H Albert; Xue-Zhong Yu; Thomas Magg
Journal:  Clin Immunol       Date:  2008-09-25       Impact factor: 3.969

5.  ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms.

Authors:  Xunrong Luo; Kathryn L Pothoven; Derrick McCarthy; Mathew DeGutes; Aaron Martin; Daniel R Getts; Guliang Xia; Jie He; Xiaomin Zhang; Dixon B Kaufman; Stephen D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-16       Impact factor: 11.205

Review 6.  Therapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune disease.

Authors:  Joseph R Podojil; Danielle M Turley; Stephen D Miller
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 7.  Exploiting apoptosis for therapeutic tolerance induction.

Authors:  Daniel R Getts; Derrick P McCarthy; Stephen D Miller
Journal:  J Immunol       Date:  2013-12-01       Impact factor: 5.422
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.